Cargando…

Identification and functional characterization of the first deep intronic GLA mutation (IVS4+1326C>T) causing renal variant of Fabry disease

BACKGROUND: Fabry disease (FD, OMIM #301500) is an X-linked lysosomal disorder caused by the deficiency of α-galactosidase A (α-GalA), encoded by the GLA gene. Among more than 1100 reported GLA mutations, few were deep intronic mutations which have been linked to classic and cardiac variants of FD....

Descripción completa

Detalles Bibliográficos
Autores principales: Dai, Xuantong, Zong, Xue, Pan, Xiaoxia, Lu, Wei, Jiang, Geng-Ru, Lin, Fujun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208104/
https://www.ncbi.nlm.nih.gov/pubmed/35725559
http://dx.doi.org/10.1186/s13023-022-02377-8
_version_ 1784729669715623936
author Dai, Xuantong
Zong, Xue
Pan, Xiaoxia
Lu, Wei
Jiang, Geng-Ru
Lin, Fujun
author_facet Dai, Xuantong
Zong, Xue
Pan, Xiaoxia
Lu, Wei
Jiang, Geng-Ru
Lin, Fujun
author_sort Dai, Xuantong
collection PubMed
description BACKGROUND: Fabry disease (FD, OMIM #301500) is an X-linked lysosomal disorder caused by the deficiency of α-galactosidase A (α-GalA), encoded by the GLA gene. Among more than 1100 reported GLA mutations, few were deep intronic mutations which have been linked to classic and cardiac variants of FD. METHODS AND RESULTS: We report a novel hemizygous deep intronic GLA mutation (IVS4+1326C>T) in a 33-year-old Chinese man with a mild α-GalA deficiency phenotype involving isolated proteinuria and predominant globotriaosylceramide deposits in podocytes. IVS4+1326C>T, which appears to be the first deep intronic GLA mutation associated with renal variant of FD, was identified by Sanger sequencing the entire GLA genomic DNA sequence of the patient’s peripheral mononuclear blood lymphocytes (PBMCs). Further sequencing of cDNA from PBMCs of the patient revealed a minor full-length GLA transcript accounting for about 25% of total GLA transcript, along with two major aberrantly spliced GLA transcripts encoding mutant forms of α-GalA with little enzyme activity characterized by in vitro α-GalA overexpression system in the HEK293T cells. Thus, the combined clinical phenotype, genetic analysis and functional studies verified the pathogenicity of IVS4+1326C>T. CONCLUSIONS: The identification of IVS4+1326C>T establishes a link between deep intronic GLA mutation and the renal variant of FD, which extends the mutation spectrum in GLA gene and justifies further study of how IVS4+1326C>T and potentially other deep intronic GLA mutations contribute to Fabry podocytopathy through aberrant splicing. Future studies should also assess the true incidence of IVS4+1326C>T in patients with different variants of FD, which may improve early genetic diagnosis to allow timely treatment that can prevent disease progression and improve survival. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13023-022-02377-8.
format Online
Article
Text
id pubmed-9208104
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-92081042022-06-21 Identification and functional characterization of the first deep intronic GLA mutation (IVS4+1326C>T) causing renal variant of Fabry disease Dai, Xuantong Zong, Xue Pan, Xiaoxia Lu, Wei Jiang, Geng-Ru Lin, Fujun Orphanet J Rare Dis Research BACKGROUND: Fabry disease (FD, OMIM #301500) is an X-linked lysosomal disorder caused by the deficiency of α-galactosidase A (α-GalA), encoded by the GLA gene. Among more than 1100 reported GLA mutations, few were deep intronic mutations which have been linked to classic and cardiac variants of FD. METHODS AND RESULTS: We report a novel hemizygous deep intronic GLA mutation (IVS4+1326C>T) in a 33-year-old Chinese man with a mild α-GalA deficiency phenotype involving isolated proteinuria and predominant globotriaosylceramide deposits in podocytes. IVS4+1326C>T, which appears to be the first deep intronic GLA mutation associated with renal variant of FD, was identified by Sanger sequencing the entire GLA genomic DNA sequence of the patient’s peripheral mononuclear blood lymphocytes (PBMCs). Further sequencing of cDNA from PBMCs of the patient revealed a minor full-length GLA transcript accounting for about 25% of total GLA transcript, along with two major aberrantly spliced GLA transcripts encoding mutant forms of α-GalA with little enzyme activity characterized by in vitro α-GalA overexpression system in the HEK293T cells. Thus, the combined clinical phenotype, genetic analysis and functional studies verified the pathogenicity of IVS4+1326C>T. CONCLUSIONS: The identification of IVS4+1326C>T establishes a link between deep intronic GLA mutation and the renal variant of FD, which extends the mutation spectrum in GLA gene and justifies further study of how IVS4+1326C>T and potentially other deep intronic GLA mutations contribute to Fabry podocytopathy through aberrant splicing. Future studies should also assess the true incidence of IVS4+1326C>T in patients with different variants of FD, which may improve early genetic diagnosis to allow timely treatment that can prevent disease progression and improve survival. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13023-022-02377-8. BioMed Central 2022-06-20 /pmc/articles/PMC9208104/ /pubmed/35725559 http://dx.doi.org/10.1186/s13023-022-02377-8 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Dai, Xuantong
Zong, Xue
Pan, Xiaoxia
Lu, Wei
Jiang, Geng-Ru
Lin, Fujun
Identification and functional characterization of the first deep intronic GLA mutation (IVS4+1326C>T) causing renal variant of Fabry disease
title Identification and functional characterization of the first deep intronic GLA mutation (IVS4+1326C>T) causing renal variant of Fabry disease
title_full Identification and functional characterization of the first deep intronic GLA mutation (IVS4+1326C>T) causing renal variant of Fabry disease
title_fullStr Identification and functional characterization of the first deep intronic GLA mutation (IVS4+1326C>T) causing renal variant of Fabry disease
title_full_unstemmed Identification and functional characterization of the first deep intronic GLA mutation (IVS4+1326C>T) causing renal variant of Fabry disease
title_short Identification and functional characterization of the first deep intronic GLA mutation (IVS4+1326C>T) causing renal variant of Fabry disease
title_sort identification and functional characterization of the first deep intronic gla mutation (ivs4+1326c>t) causing renal variant of fabry disease
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208104/
https://www.ncbi.nlm.nih.gov/pubmed/35725559
http://dx.doi.org/10.1186/s13023-022-02377-8
work_keys_str_mv AT daixuantong identificationandfunctionalcharacterizationofthefirstdeepintronicglamutationivs41326ctcausingrenalvariantoffabrydisease
AT zongxue identificationandfunctionalcharacterizationofthefirstdeepintronicglamutationivs41326ctcausingrenalvariantoffabrydisease
AT panxiaoxia identificationandfunctionalcharacterizationofthefirstdeepintronicglamutationivs41326ctcausingrenalvariantoffabrydisease
AT luwei identificationandfunctionalcharacterizationofthefirstdeepintronicglamutationivs41326ctcausingrenalvariantoffabrydisease
AT jianggengru identificationandfunctionalcharacterizationofthefirstdeepintronicglamutationivs41326ctcausingrenalvariantoffabrydisease
AT linfujun identificationandfunctionalcharacterizationofthefirstdeepintronicglamutationivs41326ctcausingrenalvariantoffabrydisease